Marimed (MRMD) Acquisitions (2019 - 2025)

Marimed (MRMD) posted quarterly Acquisitions of -$231000.0 for Q1 2025, down 105.44% quarter-over-quarter from $4.2 million in Q2 2024.

Marimed (MRMD) Acquisitions (2019 - 2025) Analysis & Trends

Marimed (MRMD) has reported Acquisitions for 5 consecutive years, with -$231000.0 the latest figure, recorded in Q1 2025.

In Q1 2025, Acquisitions changed N/A year-over-year to -$231000.0; the TTM figure through Dec 2025 stood at -$231000.0 (down 105.44% YoY), while the FY2025 annual figure was -$231000.0, down 105.44% from the prior year.
Acquisitions retreated to -$231000.0 in Q1 2025 per MRMD's latest filing, from $4.2 million in the prior quarter.
Across five years, Acquisitions topped out at $4.2 million in Q2 2024 and bottomed at -$231000.0 in Q1 2025.
Historically, Acquisitions has averaged $1.5 million across 4 years, with a median of $1.0 million in 2022.
Annual changes were most pronounced in 2023 — Acquisitions slumped 100.41% — and 2024, when it surged 53225.0%.
Marimed's Acquisitions stood at $101000.0 in 2022, then sank by 107.92% to -$8000.0 in 2023, then soared by 53225.0% to $4.2 million in 2024, then sank by 105.44% to -$231000.0 in 2025.
Business Quant data shows MRMD's Acquisitions at -$231000.0 in Q1 2025, $4.2 million in Q2 2024, and -$8000.0 in Q2 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Acquisitions (Qtr)
1	Haleon	43.98 Bn	43.02 Bn	-	-
2	Teva Pharmaceutical Industries	43.07 Bn	39.42 Bn	2.15 Bn	-
3	Zoetis	31.53 Bn	29.85 Bn	1.05 Bn	-
4	Takeda Pharmaceutical	28.60 Bn	22.80 Bn	5.10 Bn	-
5	United Therapeutics	22.13 Bn	19.47 Bn	683.80 Mn	-
6	Viatris	18.75 Bn	17.86 Bn	1.46 Bn	-
7	Neurocrine Biosciences	15.53 Bn	15.14 Bn	935.80 Mn	-
8	Elanco Animal Health	11.69 Bn	11.16 Bn	798.00 Mn	-
9	Dr Reddys Laboratories	10.13 Bn	9.97 Bn	-	-
10	Marimed	28.77 Mn	20.33 Mn	16.23 Mn	-

Download Data